Related references
Note: Only part of the references are listed.Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study
Chika Ohata et al.
JOURNAL OF DERMATOLOGY (2022)
Elderly-onset generalized pustular psoriasis: a case series
Jen-Ping Chao et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)
Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study
Akimichi Morita et al.
JOURNAL OF DERMATOLOGY (2022)
Novel IL36RN Mutation Identified in Pediatric-Onset Generalized Pustular Psoriasis Causes IL36 Antagonist Degradation
Hongmei Li et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Significance of IL36RN mutation analyses in the management of impetigo herpetiformis: A case report and review of published cases
Miyuki Yoshikawa et al.
JOURNAL OF DERMATOLOGY (2021)
IL-36 cytokines in inflammatory and malignant diseases: not the new kid on the block anymore
James Byrne et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist
Alizee Bozonnat et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments
Magdalena Misiak-Galazka et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Clinical characteristics, genetics, comorbidities and treatment of palmoplantar pustulosis: A retrospective analysis of 66 cases in a single center in Taiwan
Chang-Ming Huang et al.
JOURNAL OF DERMATOLOGY (2020)
IL-36 receptor antagonist deficiency resulted in delayed wound healing due to excessive recruitment of immune cells
Kenta Saito et al.
SCIENTIFIC REPORTS (2020)
Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis A PRISMA-compliant systematic review and meta-analysis
Zhi-Jie Liu et al.
MEDICINE (2020)
Pustular Psoriasis: The Dawn of a New Era
Herve Bachelez
ACTA DERMATO-VENEREOLOGICA (2020)
Clinical and genetic differences between pustular psoriasis subtypes
Sophie Twelves et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Two cases of generalized pustular psoriasis complicated by IgG4-related disease
H. Miyazawa et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis
Teng Zhu et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2018)
European consensus statement on phenotypes of pustular psoriasis
A. A. Navarini et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients
Ting-Shun Wang et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2016)
Impetigo herpetiformis with IL36RN mutations in a Chinese patient: A founder haplotype of c.115+6T>C in East Asia
Kazumitsu Sugiura et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2015)
Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia
Siew Eng Choon et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
Acrodermatitis Continua of Hallopeau Is a Clinical Phenotype of DITRA: Evidence that It Is a Variant of Pustular Psoriasis
Ossama Abbas et al.
DERMATOLOGY (2013)
Mutation Analysis of the IL36RN Gene in 14 Japanese Patients with Generalized Pustular Psoriasis
Muhammad Farooq et al.
HUMAN MUTATION (2013)
The Majority of Generalized Pustular Psoriasis without Psoriasis Vulgaris Is Caused by Deficiency of Interleukin-36 Receptor Antagonist
Kazumitsu Sugiura et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)